155 related articles for article (PubMed ID: 11979108)
1. Two long terminal repeat circles and persistent HIV-1 replication.
Sharkey ME; Stevenson M
Curr Opin Infect Dis; 2001 Feb; 14(1):5-11. PubMed ID: 11979108
[TBL] [Abstract][Full Text] [Related]
2. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
Pierson T; McArthur J; Siliciano RF
Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
[TBL] [Abstract][Full Text] [Related]
3. The challenge of viral reservoirs in HIV-1 infection.
Blankson JN; Persaud D; Siliciano RF
Annu Rev Med; 2002; 53():557-93. PubMed ID: 11818490
[TBL] [Abstract][Full Text] [Related]
4. Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence.
Martinez-Picado J; Zurakowski R; Buzón MJ; Stevenson M
Retrovirology; 2018 Jan; 15(1):15. PubMed ID: 29378611
[TBL] [Abstract][Full Text] [Related]
5. Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication.
Pierson TC; Kieffer TL; Ruff CT; Buck C; Gange SJ; Siliciano RF
J Virol; 2002 Apr; 76(8):4138-44. PubMed ID: 11907256
[TBL] [Abstract][Full Text] [Related]
6. LGIT In Vitro Latency Model in Primary and T Cell Lines to Test HIV-1 Reactivation Compounds.
Jung U; Takahashi M; Rossi JJ; Burnett JC
Methods Mol Biol; 2016; 1354():255-64. PubMed ID: 26714717
[TBL] [Abstract][Full Text] [Related]
7. HAART-persistent HIV-1 latent reservoirs: their origin, mechanisms of stability and potential strategies for eradication.
Kulkosky J; Bray S
Curr HIV Res; 2006 Apr; 4(2):199-208. PubMed ID: 16611058
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Spontaneous Control of HIV-1 Is Related to Low Frequency of Infected Cells and Inefficient Viral Reactivation.
Noel N; Peña R; David A; Avettand-Fenoel V; Erkizia I; Jimenez E; Lecuroux C; Rouzioux C; Boufassa F; Pancino G; Venet A; Van Lint C; Martinez-Picado J; Lambotte O; Sáez-Cirión A; Prado JG
J Virol; 2016 Jul; 90(13):6148-6158. PubMed ID: 27122576
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus type 1-infected persons with residual disease and virus reservoirs on suppressive highly active antiretroviral therapy can be stratified into relevant virologic and immunologic subgroups.
Dornadula G; Nunnari G; Vanella M; Roman J; Babinchak T; DeSimone J; Stern J; Braffman M; Zhang H; Pomerantz RJ
J Infect Dis; 2001 Jun; 183(11):1682-7. PubMed ID: 11343220
[TBL] [Abstract][Full Text] [Related]
10. Measuring covert HIV replication during HAART: the abundance of 2-LTR circles is not a reliable marker.
Bushman F
AIDS; 2003 Mar; 17(5):749-50. PubMed ID: 12646799
[No Abstract] [Full Text] [Related]
11. HIV reservoirs: pathogenesis and obstacles to viral eradication and cure.
Chun TW; Fauci AS
AIDS; 2012 Jun; 26(10):1261-8. PubMed ID: 22472858
[TBL] [Abstract][Full Text] [Related]
12. Peripheral T Follicular Helper Cells Are the Major HIV Reservoir within Central Memory CD4 T Cells in Peripheral Blood from Chronically HIV-Infected Individuals on Combination Antiretroviral Therapy.
Pallikkuth S; Sharkey M; Babic DZ; Gupta S; Stone GW; Fischl MA; Stevenson M; Pahwa S
J Virol; 2015 Dec; 90(6):2718-28. PubMed ID: 26676775
[TBL] [Abstract][Full Text] [Related]
13. Slow human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy.
Persaud D; Ray SC; Kajdas J; Ahonkhai A; Siberry GK; Ferguson K; Ziemniak C; Quinn TC; Casazza JP; Zeichner S; Gange SJ; Watson DC
AIDS Res Hum Retroviruses; 2007 Mar; 23(3):381-90. PubMed ID: 17411371
[TBL] [Abstract][Full Text] [Related]
14. Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure.
Ruff CT; Ray SC; Kwon P; Zinn R; Pendleton A; Hutton N; Ashworth R; Gange S; Quinn TC; Siliciano RF; Persaud D
J Virol; 2002 Sep; 76(18):9481-92. PubMed ID: 12186930
[TBL] [Abstract][Full Text] [Related]
15. Increased T cell trafficking as adjunct therapy for HIV-1.
Fryer HR; Wolinsky SM; McLean AR
PLoS Comput Biol; 2018 Mar; 14(3):e1006028. PubMed ID: 29499057
[TBL] [Abstract][Full Text] [Related]
16. Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents.
Passaes CPB; Bruel T; Decalf J; David A; Angin M; Monceaux V; Muller-Trutwin M; Noel N; Bourdic K; Lambotte O; Albert ML; Duffy D; Schwartz O; Sáez-Cirión A
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077644
[TBL] [Abstract][Full Text] [Related]
17. Basal shuttle of NF-kappaB/I kappaB alpha in resting T lymphocytes regulates HIV-1 LTR dependent expression.
Coiras M; López-Huertas MR; Rullas J; Mittelbrunn M; Alcamí J
Retrovirology; 2007 Aug; 4():56. PubMed ID: 17686171
[TBL] [Abstract][Full Text] [Related]
18. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
[TBL] [Abstract][Full Text] [Related]
19. The Pathway To Establishing HIV Latency Is Critical to How Latency Is Maintained and Reversed.
Rezaei SD; Lu HK; Chang JJ; Rhodes A; Lewin SR; Cameron PU
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643247
[TBL] [Abstract][Full Text] [Related]
20. Measuring replication competent HIV-1: advances and challenges in defining the latent reservoir.
Wang Z; Simonetti FR; Siliciano RF; Laird GM
Retrovirology; 2018 Feb; 15(1):21. PubMed ID: 29433524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]